These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 34050931)

  • 41. Comparison of an ordinal endpoint to time-to-event, longitudinal, and binary endpoints for use in evaluating treatments for severe influenza requiring hospitalization.
    Peterson RL; Vock DM; Babiker A; Powers JH; Hunsberger S; Angus B; Paez A; Neaton JD;
    Contemp Clin Trials Commun; 2019 Sep; 15():100401. PubMed ID: 31312748
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial.
    Takayama S; Namiki T; Ito T; Arita R; Nakae H; Kobayashi S; Yoshino T; Ishigami T; Tanaka K; Kainuma M; Nochioka K; Takagi A; Mimura M; Yamaguchi T; Ishii T
    Trials; 2020 Oct; 21(1):827. PubMed ID: 33008479
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Need for More Randomized Controlled Trials With Rigorous Methodology to Confirm That Ivermectin Is Not a Viable Option for the Treatment of Coronavirus Disease 2019.
    Banno M; Tsujimoto Y; Ishikane M
    Clin Infect Dis; 2022 Mar; 74(6):1121-1122. PubMed ID: 34358296
    [No Abstract]   [Full Text] [Related]  

  • 44. Mega randomized clinical trials: a definitive solution or a double-edged sword?
    Lemaitre F; Laviolle B
    Eur J Clin Pharmacol; 2022 Feb; 78(2):305-306. PubMed ID: 34651199
    [No Abstract]   [Full Text] [Related]  

  • 45. Multigroup, Adaptively Randomized Trials Are Advantageous for Comparing Coronavirus Disease 2019 (COVID-19) Interventions.
    Magaret AS; Jacob ST; Halloran ME; Guthrie KA; Magaret CA; Johnston C; Simon NR; Wald A
    Ann Intern Med; 2020 Oct; 173(7):576-577. PubMed ID: 32525715
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A note on non-parametric ANCOVA for covariate adjustment in randomized clinical trials.
    Lesaffre E; Senn S
    Stat Med; 2003 Dec; 22(23):3583-96. PubMed ID: 14652862
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nonparametric adjustment techniques for binary covariates.
    Berger VW
    Biom J; 2005 Apr; 47(2):199-205. PubMed ID: 16389917
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fluvoxamine for COVID-19?
    Med Lett Drugs Ther; 2021 May; 63(1623):69-70. PubMed ID: 33976099
    [No Abstract]   [Full Text] [Related]  

  • 49. Deploying Randomized Controlled Trials during the COVID-19 Pandemic: Reason and Bayesian Designs.
    Zampieri FG
    Ann Am Thorac Soc; 2020 Aug; 17(8):937-938. PubMed ID: 32735169
    [No Abstract]   [Full Text] [Related]  

  • 50. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adaptive covariate adjustment in clinical trials.
    Wang SJ; Hung HM
    J Biopharm Stat; 2005; 15(4):605-11. PubMed ID: 16022166
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Macrolides for the treatment of COVID-19: a living, systematic review.
    Verdejo C; Vergara-Merino L; Meza N; Pérez-Bracchiglione J; Carvajal-Juliá N; Madrid E; Rada G; Rojas Reyes MX
    Medwave; 2020 Dec; 20(11):e8074. PubMed ID: 33361755
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Covariate adjustment increases statistical power in randomized controlled trials.
    Lingsma H; Roozenbeek B; Steyerberg E;
    J Clin Epidemiol; 2010 Dec; 63(12):1391; author reply 1392-3. PubMed ID: 20800991
    [No Abstract]   [Full Text] [Related]  

  • 54. Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics.
    Kalil AC
    JAMA; 2020 May; 323(19):1897-1898. PubMed ID: 32208486
    [No Abstract]   [Full Text] [Related]  

  • 55. Serious Concerns About the RCT Study Quality of Traditional Chinese Medicine Injections for Treating Cardiovascular Diseases and COVID-19.
    Gao G; Leung SW; Jia Y
    Cardiovasc Drugs Ther; 2021 Feb; 35(1):191-193. PubMed ID: 32785792
    [No Abstract]   [Full Text] [Related]  

  • 56. Ivermectin as a potential treatment for COVID-19?
    Chosidow O; Bernigaud C; Guillemot D; Giraudeau B; Lespine A; Changeux JP; Bourhy H; Lecuit M; Amoura Z
    PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009446. PubMed ID: 34061842
    [No Abstract]   [Full Text] [Related]  

  • 57. Generating randomized trial evidence to optimize treatment in the COVID-19 pandemic.
    Cheng MP; Lee TC; Tan DHS; Murthy S
    CMAJ; 2020 Apr; 192(15):E405-E407. PubMed ID: 32336678
    [No Abstract]   [Full Text] [Related]  

  • 58. Efficacy and safety of nitazoxanide in treating SARS-CoV-2 infection: a systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials.
    Martins-Filho PR; do Nascimento-Júnior EM; Barreto-Alves JA; Fakhouri R; Ferreira LC
    Eur J Clin Pharmacol; 2022 Nov; 78(11):1813-1821. PubMed ID: 36066651
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Covariate adjustment for two-sample treatment comparisons in randomized clinical trials: a principled yet flexible approach.
    Tsiatis AA; Davidian M; Zhang M; Lu X
    Stat Med; 2008 Oct; 27(23):4658-77. PubMed ID: 17960577
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A pilot study of therapeutic plasma exchange for serious SARS CoV-2 disease (COVID-19): A structured summary of a randomized controlled trial study protocol.
    Faqihi F; Alharthy A; Alodat M; Asad D; Aletreby W; Kutsogiannis DJ; Brindley PG; Karakitsos D
    Trials; 2020 Jun; 21(1):506. PubMed ID: 32513290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.